EUVIMEDEUVIMED entdecken
Crossref

Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes

Omer Gal, Jen Yu, Minesh P Mehta, Matthew D Hall, Robert H Press, Yazmin Odia, Michael W McDermott, Zachary Fellows, Andrew Wroe, Alonso N Gutierrez, Rupesh Kotecha

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.03.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Omer Gal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida. Hauptthemen laut MEDLINE: Proton Therapy, Brain Neoplasms, Radiotherapy, Intensity-Modulated, Radiation Injuries. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Patients treated with intensity modulated proton therapy (IMPT) may develop intracranial radiation-induced contrast enhancement (RICE). The incidence, distribution, kinetics, predisposing factors, linear energy of transfer (LET) associations, and clinical outcomes of RICE are inadequately defined. METHODS AND MATERIALS: The incidence and characteristics of RICE were analyzed in brain tumor patients treated with at least 50 Gy IMPT, 1-year follow-up, and 3 posttreatment magnetic resonance imaging scans. RICE distribution was classified as overlapping with tumor/tumor bed (A), inside or marginal to high-dose region (≤5 mm from the 95% isodose line [IDL]) (B), or distant (>5 mm from 95% IDL) (C). Voxelized dose and LET were computed for each RICE lesion. Risk factors were assessed using binary logistic regression. RESULTS: With a median follow-up of 3 years, 73 RICE lesions were observed in 36 of 137 patients (26%), appearing at a median of 11 months post-IMPT. Group-wise distribution demonstrated 10 (28%), 24 (67%), and 2 (5%) lesions in groups A, B, and C, respectively. Ten (7% overall) patients were symptomatic. After a median of 5 months, most lesions (78%) improved or resolved. Median dose and LET in RICE lesions were 50.4 Gy and 3.1 keV/µm. RICE risk increased with age as a continuous variable (0.4%/year), age ≥18 years (odds ratio [OR], 5.4), tumor volume >30 cc (OR, 2.8), and 95% IDL overlapping the ventricles (OR, 3.8). CONCLUSIONS: RICE is a common radiographic finding after IMPT, primarily occurring in the periventricular and high-dose regions, but is infrequently symptomatic. Periventricular-sparing treatment may be considered to minimize the risk of RICE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyBrain NeoplasmsRadiotherapy, Intensity-ModulatedRadiation InjuriesContrast MediaHumansMaleMiddle AgedFemaleAdultRisk FactorsMagnetic Resonance ImagingAgedLinear Energy TransferFollow-Up StudiesYoung AdultRadiotherapy DosageAdolescentTumor BurdenIncidenceChildBrainTreatment Outcome

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida; Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • Herbert Wertheim College of Medicine, Florida International University, Miami, Florida; Department of Neuro-Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Herbert Wertheim College of Medicine, Florida International University, Miami, Florida; Department of Neurosurgery, Miami Neuroscience Institute, Baptist Health South Florida, Miami, Florida.
  • Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida; Herbert Wertheim College of Medicine, Florida International University, Miami, Florida. Electronic address: rupeshk…

Zitieren

APA

Gal, O., Yu, J., Mehta, M. P., Hall, M. D., Press, R. H., Odia, Y., McDermott, M. W., Fellows, Z., Wroe, A., Gutierrez, A. N., & Kotecha, R. (2025). Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.03.025

Vancouver

Gal O, Yu J, Mehta MP, Hall MD, Press RH, Odia Y, et al. Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.03.025

BibTeX
@article{Gal2025,
  author = {Gal, Omer and Yu, Jen and Mehta, Minesh P and Hall, Matthew D and Press, Robert H and Odia, Yazmin and McDermott, Michael W and Fellows, Zachary and Wroe, Andrew and Gutierrez, Alonso N and Kotecha, Rupesh},
  title = {Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.03.025}
}
Kostenlos starten →